Fraction of cervical neoplasias due to human papillomavirus 16 and 18 in vaccine trials.
Franceschi
Silvia
S
Clifford
Gary M
GM
D000230:Adenocarcinoma / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D000293:Adolescent; D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D002986:Clinical Trials as Topic; D005260:Female; D052162:Human papillomavirus 16 / Q000472:pathogenicity*; D052161:Human papillomavirus 18 / Q000472:pathogenicity*; D006801:Humans; D009361:Neoplasm Invasiveness / Q000473:pathology / Q000517:prevention & control; D053918:Papillomavirus Vaccines; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines